Numeric Investors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Numeric Investors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,000	Closed	-$716K	–	1204
2016 Q1	$716K	Sell	5,000 -11,400	-70%	-$1.62M	0.01%	610
2015 Q4	$2.54M	Buy	+16,400	New	+$2.39M	0.03%	402
2014 Q4	–	Sell	-8,200	Closed	-$1.26M	–	1000
2014 Q3	$1.26M	Buy	+8,200	New	+$1.23M	0.02%	392

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Numeric Investors's TARO Position: Q2 2016 in Review

Numeric Investors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2016, closing a stake of 5,000 shares — an estimated $716K sold.

Numeric Investors first reported a position in TARO in Q3 2014 and held it in 3 quarters. The position peaked at $2.54M in Q4 2015. 159 funds tracked by Wall St. Rank hold TARO as of Q2 2016.

Numeric Investors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2016 after selling out during the quarter.
Numeric Investors sold 5,000 Taro Pharmaceutical Industries Ltd. shares in Q2 2016, an estimated $716K.
Numeric Investors first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2014 and held it in 3 quarters.
Numeric Investors's Taro Pharmaceutical Industries Ltd. position peaked at $2.54M in Q4 2015.
159 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2016.

Based on Numeric Investors's 13F filing for Q2 2016, filed 16 Aug 2016.